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Abstract Mammalian calcium receptors (CaRs) share with the
metabotropic glutamate receptors (mGluRs) the relative posi-
tions of 16 cysteine residues in the amino-terminal extracellular
domain. To investigate the role of these cysteines, a series of
mutants in the extracellular domain of the human CaR was
prepared in which each of these 16 cysteine residues and three
others not conserved in the mGluRs were replaced by serines.
Wild-type and mutant CaR cDNAs were expressed in HEK-293
cells, and evaluated for expression and response to extracellular
calcium. Mutation of three non-conserved cysteines and of two
conserved cysteines produced proteins with near wild-type
phenotype. In contrast, mutation of the other conserved cysteines
gave proteins that showed drastic reduction in cell surface
expression and/or failed to respond to calcium. We identified
14 cysteines essential for proper trafficking and function of
the receptor, two of which may be involved in formation of a
disulfide-linked dimer.
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1. Introduction
The calcium receptor (CaR) is a G protein-coupled receptor
that plays a central role in extracellular calcium homeostasis
by mediating the e¡ect of extracellular Ca2 on parathyroid
hormone secretion and on renal calcium excretion [1]. In ad-
dition to the parathyroids and kidney, the CaR is expressed in
brain, intestine, skin, and other organs where it may mediate
the e¡ects of extracellular Ca2 on a variety of other cellular
functions such as ion channel activity and proliferation [2].
While the CaR shares with other members of the superfamily
of G protein-coupled receptors a characteristic seven trans-
membrane-domain structure, its sequence and topography
are otherwise unique. In particular, the CaR possesses a large
(V600 amino acid), amino-terminal extracellular domain
(ECD) which was noted [3,4] to be similar in length and to
a limited extent in amino acid sequence to the ECD of the
metabotropic glutamate receptors (mGluRs), themselves a
unique subfamily of G protein-coupled receptors [5,6]. A dis-
tinctive feature of the CaR ECD is the presence of 19 cysteine
residues, nine clustered between residues 542 and 598 of the
human CaR (hCaR) sequence in what has been termed a
cysteine-rich region, and the remaining ten scattered within
the ¢rst 500 residues of the ECD.
All 19 of these cysteines are conserved in mammalian CaRs
including human [4], bovine [3], rat [7,8] and rabbit [9], and all
but cysteine 482 (hCaR sequence) are conserved in the chicken
CaR [10]. Sixteen of the 19 cysteines (all except residues 129,
437, and 482 of the hCaR) are conserved in the identical
positions in the amino-terminal ECDs of the seven members
of the mGluR subfamily of G protein-coupled receptors [6].
The conservation of CaR ECD cysteines among di¡erent spe-
cies, and between the CaR and mGluRs, suggests an impor-
tant role for these cysteines in the structure and perhaps func-
tion of these receptors. Although these conserved ECD
cysteines have been noted by several groups who have specu-
lated on their potential signi¢cance [3,5], and there is evidence
that both mGluRs and the CaR form disul¢de-linked dimers
[11^13], experimental studies to de¢ne the role of speci¢c
ECD cysteines have not been done for either the CaR or
mGluRs. As an initial step in de¢ning the role of the ECD
cysteines in CaR structure and function, we mutated each of
the individual 19 ECD cysteines to serine, and assessed the
ability of the mutant receptors to be expressed, to tra⁄c to
the cell surface, to form dimers, and to activate phosphoinosi-
tide (PI) hydrolysis in response to extracellular Ca2.
2. Materials and methods
2.1. Site-directed mutagenesis of the hCaR
Site-directed mutagenesis was performed using QuikChange Site-
directed Mutagenesis Kit (Stratagene, La Jolla, CA, USA) on the
hCaR cDNA ampli¢ed by polymerase chain reaction from a Pituitary
Marathon cDNA library (Promega, Madison, WI, USA) and cloned
into pCR 3.1 (Invitrogen, San Diego, CA, USA) mammalian expres-
sion vector as previously described [14]. The complementary primer
pairs used are available on request from the authors. The presence of
cysteine to serine point mutations and the absence of other mutations
were con¢rmed by automated DNA sequencing using ABI prizm-377
DNA sequencer (Applied Biosystems, Foster City, CA, USA).
2.2. Transient expression of wild-type and mutant hCaR receptors in
HEK-293 cells
Receptor cDNAs in pCR 3.1 were prepared by Qiagen maxi-plas-
mid DNA preparation kit (Qiagen, Chatsworth, CA, USA) and were
transfected into HEK-293 cells using lipofectamine (Life Technolo-
gies, Gaithersburg, MD, USA) as previously described [14], using
0.5 Wg of DNA per well on 24-well plates (for phosphoinositide (PI)
hydrolysis assay), in 6-well plates using 1 Wg of DNA (for intact cell
ELISA), and in 75-mm £asks using 10 Wg of DNA (for immunoblot
analysis). Membrane protein extraction for immunoblotting, intact
cell ELISA and PI hydrolysis assay were performed 48 h after trans-
fection, as previously described [14].
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3. Results
3.1. Immunoblot analysis of the expression of hCaR
cysteineCserine mutants
Wild-type and 19 di¡erent cysteineCserine mutant hCaR
cDNAs were transiently transfected in HEK-293 cells, and
expression assessed by immunoblot. The peptide used to gen-
erate the ADD monoclonal antibody used for immunoblot
includes none of the 19 ECD cysteines. Also, the ADD mono-
clonal antibody has been shown to bind strongly to the dena-
tured CaR and CaR ECD [15]. Thus, as long as some receptor
protein was expressed, we expected the ADD monoclonal to
recognize each of the cysteine mutant CaRs on immunoblots,
even if the mutation caused misfolding and/or impaired pro-
tein processing and tra⁄cking. Membrane preparations of
cells transfected with vector containing the wild-type hCaR
cDNA showed a characteristic pattern (Fig. 1) consisting of
a doublet of V150 kDa and V130 kDa, representing fully
glycosylated and incompletely processed, high mannose forms
of the CaR, respectively, and a higher molecular weight smear
which may represent dimeric forms of the receptor as previ-
ously reported [13,14,16,17]. Immunoblots of membranes
from HEK-293 cells transfected with vector alone showed
no immunoreactivity [15,17]. The cysteine mutants fell into
two broad classes based on the immunoblotting shown in
Fig. 1. Expression of C129S, C131S, C437S, C449S and
C482S mutants gave products similar to those obtained with
the wild type with prominent V150-kDa and V130-kDa
bands. All the other cysteine to serine mutants showed mark-
edly decreased immunostaining of the 150-kDa band, but re-
tained strong immunostaining of the 130-kDa band.
3.2. Intact cell enzyme-linked immunoassay to assess cell
surface expression level of hCaR cysteine mutants
To determine the level of cell surface expression of the
mutant receptors, we took advantage of an intact cell ELISA
using monoclonal antibodies raised against the puri¢ed ECD
of the hCaR, 7F8 and 7B10. Both of these antibodies bind to
the native hCaR expressed in HEK 293 cells (P.K. Goldsmith
and A.M. Spiegel, manuscript in preparation). As illustrated
in Fig. 2, the optical densities (measured with antibody 7F8)
indicated that the C129S, C131S and C482S mutant receptors
were expressed at a level close to that of the wild-type receptor
(88%, 97% and 89%, respectively). OD values for C437S and
C449S mutants were signi¢cantly lower (64% and 65% of wild
type, respectively). The C60S and C598S mutants showed a
cell surface expression nearly half of that of the wild-type
receptor. Very low levels of cell surface expression (from not
detectable to 28%) were observed in the other mutants. Intact
cell ELISA using another monoclonal antibody raised against
the puri¢ed ECD, 7B10, gave similar results (data not
shown).
3.3. Analysis of signal transduction by cysteine mutant
receptors using phosphoinositide hydrolysis assay
Since the CaR responds to increases in [Ca2]o by activating
Gq family proteins to stimulate PLC-L activity with resultant
PI hydrolysis, we analyzed the e¡ect of increasing [Ca2]o on
the accumulation of inositol phosphates in transfected HEK-
293 cells to measure signal transduction by expressed wild-
type and mutant CaRs. Three cysteine mutants, C129S,
C131S and C482S, showed Ca2 response similar to that of
the wild type-receptor (Fig. 3). Two other cysteine mutants,
C437S and C449S, showed a rightward shift of the Ca2 con-
centration-response curve with a decreased maximal response
(Fig. 3). In contrast, all other cysteine mutant receptors
showed no signi¢cant PI hydrolysis response to [Ca2]o even
up to 20 mM (data not shown), a result equivalent to that
seen with cells transfected with vector alone (Fig. 3).
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Fig. 1. Immunoblot showing the expression pattern of wild-type
hCaR and cysteineCserine mutants transiently expressed in HEK-
293 cells. Crude membrane extracts were obtained from HEK-293
cells that were transiently transfected with wild-type hCaR and dif-
ferent cysteineCserine mutant plasmid cDNAs as described in Sec-
tion 2. 60 Wg of membrane protein from cells transfected with each
receptor were loaded in each lane (labeled at top; WT = wild type),
and resolved on 5^15% gradient gel by SDS-polyacrylamide gel elec-
trophoresis. Immunoblotting was performed with 0.1 Wg/ml mono-
clonal anti-hCaR antibody ADD raised against a synthetic peptide
corresponding to residues 214^235 of hCaR [15]. The positions of
molecular size standards are indicated at the right.
Fig. 2. Intact cell enzyme-linked immunoassay for quantitation of
cell surface expression of wild-type and cysteineCserine mutant
hCaRs. HEK-293 cells in 6-well plates were transfected with 1 Wg/
well of wild-type or cysteineCserine mutant hCaR cDNAs. Cells in
suspension were incubated with 1 Wg/ml 7F8 or 7B10 monoclonal
hCaR antibody raised against the puri¢ed hCaR ECD and with
peroxidase-conjugated anti-mouse immunoglobin secondary anti-
body as described in Section 2. Peroxidase substrate was added and
OD was measured at 405 nm. The OD readings are expressed as a
per cent of the value for the wild-type hCaR (set at 100%) using
HEK-293 cells transfected with vector alone as the negative control.
Each point represents the mean þ S.E.M. of duplicate determinations
from three independent experiments.
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3.4. Immunoblot analysis of the expression of wild-type and
cysteine mutant hCaRs under non-reducing and reducing
conditions
Since the CaR expressed endogenously in rat kidney has
been reported to form disul¢de-linked dimers [13], we per-
formed immunoblots under reducing and non-reducing con-
ditions of membranes from HEK-293 cells transfected with
wild-type and cysteine mutant hCaR cDNAs. As reported
previously [14,16], even under reducing conditions (Fig. 4,
right) considerable immunoreactivity is detected not only in
the size range (130^150 kDa) of monomeric receptor species,
but also in a higher size range corresponding to putative di-
meric forms of receptor. Under non-reducing conditions (Fig.
4, left), immunostaining of monomers is no longer detectable
for wild-type CaR and for cysteine mutants such as C131S
which behaves in other assays like wild type or C598S which
is non-functional in terms of PI response to calcium. In con-
trast, C60S and C101S mutants show distinct immunostaining
of monomeric CaR and proportionately less immunoreactivity
in the dimer size range even under non-reducing conditions.
4. Discussion
There have been numerous previous mutagenesis studies on
cysteines in G protein-coupled receptors, but almost all have
focused on a pair of disul¢de-linked cysteines in the 1st and
2nd extracellular loops. It has been estimated that s 90% of
G protein-coupled receptors contain cysteines in these two
loops, and many studies suggest that disul¢de linkage of the
1st and 2nd extracellular loops via these cysteines is important
for G protein-coupled receptor structure and function (see for
example [18] and references therein).
The CaR and all members of the mGluR subfamily have
cysteines in the 1st and 2nd extracellular loops (residues 677
and 765, respectively, in the hCaR). As in other G protein-
coupled receptors, these cysteines may be disul¢de-linked and
may be important for maintaining the structure of the seven
membrane-spanning helices, but these cysteines were not the
focus of the present study. Instead, we chose to focus on the
large number of cysteines located in the amino-terminal ECD,
most of which are conserved between the CaR and mGluRs.
These conserved cysteines are not found in other G protein-
coupled receptors, and no previous studies have examined
their functional signi¢cance.
Recently, a new family of putative pheromone receptors
was cloned from the vomeronasal organ [19^21]. The pre-
dicted structure of members of this family is similar to that
of the CaR and mGluRs with a large amino-terminal ECD in
addition to the seven membrane-spanning helices. Two mem-
bers of this family, designated mV2R1 and mV2R2, in fact,
are more closely related in sequence to the CaR than is any
mGluR [19]. In particular, all nine cysteines of the cysteine-
rich region are conserved in this new family and four other
cysteines (equivalent to residues 236, 358, 395 and 449 in the
hCaR) are also conserved in mV2R1 and mV2R2. Given the
high degree of conservation of many of the cysteines in the
amino-terminal ECD of the CaR, mGluRs and vomeronasal
organ putative pheromone receptors, we sought to de¢ne the
importance of each cysteine in the CaR amino-terminal ECD
by mutagenesis and expression studies.
Our results indicate that 14 of these cysteines, including all
nine in the cysteine-rich region, are essential for normal re-
ceptor expression at the cell surface, and normal function in
mediating activation by extracellular Ca2. Each of these mu-
tant receptors was capable of being expressed as a protein
visualized on immunoblots of transfected 293 cell membranes,
but in most cases, the protein was primarily in the form of an
V130-kDa band previously shown to re£ect an incompletely
processed, high mannose form of the receptor (sensitive to
endo H sugar cleavage) that does not tra⁄c to the plasma
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Fig. 4. Immunoblot under non-reducing and reducing conditions
showing the expression pattern of wild-type hCaR and cystei-
neCserine mutants transiently expressed in HEK-293 cells. Crude
membrane extracts were prepared and immunoblots performed as in
the legend to Fig. 1 except that SDS-PAGE was performed under
non-reducing conditions without addition of L-mercaptoethanol
(3Lmercap) as well as under standard reducing conditions with 2%
L-mercaptoethanol (+Lmercap).
Fig. 3. Concentration dependence for calcium stimulation of phos-
phoinositide hydrolysis in transiently transfected HEK-293 cells ex-
pressing wild-type (WT) and cysteineCserine mutant cDNAs.
Transfections were performed, and calcium-stimulated PI hydrolysis
assayed as described in Section 2. For each experiment, calcium
concentrations were assayed in triplicate. Results are expressed in
counts/min of total labeled inositol phosphates generated. Each data
point is the mean þ S.E.M. of six independent transfections.
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membrane but is likely retained in the endoplasmic reticulum
[14,16]. For some mutants such as cysteines 395 and 546, there
appeared to be a decrease even in this form of the protein,
perhaps re£ecting more rapid proteolytic degradation. The
results of cell surface ELISA, a direct measure of receptor
expression at the cell surface, in general correlated well with
the reduction in an V150-kDa form of the protein seen on
immunoblot. The latter has been shown to represent a fully
glycosylated and processed form of the receptor (endo H re-
sistant) that tra⁄cs to the cell surface [14,16]. Cell surface
ELISA of all mutants was performed with two di¡erent
ECD monoclonal antibodies with similar results making it
likely that reduced ELISA signal re£ects decreased cell surface
expression rather than failure of antibody to react with mu-
tant forms of the receptor. None of the 14 cysteine mutants
was capable of being activated by extracellular Ca2 even at
concentrations up to 20 mM. Interestingly, a naturally occur-
ring loss of function mutation of the hCaR, cysteine 582 to
tyrosine, was identi¢ed in a subject with neonatal severe pri-
mary hyperparathyroidism [22]. Functional studies on this
mutant were not performed, but our study indicates that cys-
teine 582 is critical for receptor function.
In contrast, mutation of ¢ve other cysteines caused either
no signi¢cant change in any parameter compared with wild
type (C129, C131, C482) or a reduction compared with wild
type but with retention of substantial response to Ca2 (C437,
C449). Three of the ¢ve cysteines that could be mutated with-
out loss of function are the three cysteines in the ECD not
conserved between CaR and mGluRs. C131, although con-
served between CaR and mGluRs is not conserved in the
vomeronasal organ receptors, mV2R21 and mV2R2. Only
C449 is conserved in CaR, mGluRs and V2Rs.
Our study de¢nes the critical importance of 14 of the ami-
no-terminal ECD cysteines of the CaR, but does not reveal
how substitution of serine for each of these cysteines impairs
receptor function. It is tempting to speculate that many of
these cysteines are involved in intramolecular disul¢de link-
ages critical for normal cotranslational folding and glycosyla-
tion of the amino-terminal ECD as the nascent polypeptide
chain is translocated into the lumen of the endoplasmic retic-
ulum. A model for the ECD of the mGluRs (which given the
sequence homology can be extended to the CaR) based on the
known 3-D structure of bacterial periplasmic binding proteins
is compatible with the presence of at least 8^10 cysteines that
could be disul¢de-linked [23]. The loss of function of the CaR
we observe upon mutation of ECD cysteines could be due to
loss of normal disul¢de linkage with resultant misfolding, ag-
gregation, and retention and degradation in the endoplasmic
reticulum.
Failure of mutant receptors to reach the cell surface could
by itself account for loss of function, but in some cases loss of
function due to abnormal structure could occur even with
some mutant receptor reaching the cell surface. Evidence
that the CaR [13] and closely related mGluRs form dimers
due to disul¢de linkage [11,12] suggests that mutation of ECD
cysteines could impair intermolecular and not only intramo-
lecular disul¢de bond formation. Tryptic proteolysis studies of
mGluR5 localized putative intermolecular disul¢de(s) in-
volved in dimer formation to the N-terminal 17 kDa of the
ECD [11]. Our observation that substantial amounts of C60S
and C101S mutants were expressed as monomers even under
non-reducing conditions suggests that both of these cysteines
within the N-terminal portion of the ECD may be involved in
intermolecular disul¢des and dimer formation. Given the loss
of calcium response of both the C60S and C101S mutants
despite signi¢cant levels of cell surface expression, particularly
for C60S, dimer formation may be critical for signal trans-
duction. Future biochemical studies of the puri¢ed receptor
and/or ECD will be aimed at de¢ning the number and loca-
tion of disul¢des in the CaR and their speci¢c role in receptor
structure and function.
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